Last reviewed · How we verify

NCT04821544

Maternal Stress on Human Milk and Infant Outcomes

Recruiting now NA Last updated 18 May 2025
What this trial tests

NA trial testing Mindfulness-based intervention (with a focus on self-compassion; MBSC) in Postpartum Depression in 500 participants. Currently enrolling.

Timeline
1 May 2021
Primary endpoint
30 June 2027
30 June 2027

Quick facts

Lead sponsorUniversity of Idaho
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment500
Start date1 May 2021
Primary completion30 June 2027
Estimated completion30 June 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Idaho

Who can join

Adults 18 to 50, female only, with Postpartum Depression or Preterm Labor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overarching purpose of this study is to determine if a modified 8-week mindfulness-based intervention (with a focus on self-compassion; MBSC) or 8 weeks of 2000 IU vitamin D supplementation will reduce stress and increase self-compassion in mothers of preterm infants and beneficially modify the human milk produced, and subsequently improve infant health.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postpartum Depression

Currently open trials in the same condition.

Other University of Idaho trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04821544.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing